Coming to a Community Near You: Reentry National Crime Prevention Council 2006 Drew Carberry.
Executing Global Clinical Trial Operations Katz, PhD Purdue SPEED OF RECRUITMENT Peter Carberry, MD...
Transcript of Executing Global Clinical Trial Operations Katz, PhD Purdue SPEED OF RECRUITMENT Peter Carberry, MD...
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
Special Coverage on:
• The Economics of Global Trials and SPA
• Regulatory Updates with invited speaker Ni Khin, MD, Medical Team
Leader, US Food & Drug Administration
• Patient Recruitment: 3-Part Section on Recruitment Speed,
Globalizing your Study, Social Media & Communication & Privacy
Hot Topic Discussions:
• Managing Global Clinical Studies During an Acquisition
• Cultural Impact on Study Execution
• Optimizing Resource Utilization
• Using Data Mining Techniques to Identify Patient Locations
Featured Panels:
• How to Investigate and Identify the right KOL and CRO for your trial
implementation
• It’s A Team Effort! Best Practices in Executing Global Trials with Sponsors,
CROs and Investigators
Round Tables by Region:
Latin America ● Eastern Europe ● China
Korea ● Europe ● India ● Japan
Executing Global Clinical Trial Operations
How to globalize your study for clinical success
September 28 - 29, 2010
Embassy Suites Washington DC - Convention Center
HIGHLIGHTSSTATE OF THE INDUSTRY ADDRESS
Mitchell Katz, PhD Purdue
SPEED OF RECRUITMENTPeter Carberry, MDAstellas
CLINICAL PARTNERSRaymond Panas, PhDSucampoPharmaceuticals
REGIONAL REGULATIONSGene Wright, PharmD, PhDCombinatoRx
EMERGING MARKETSAleksander Skuban, MDOtsuka Pharmaceutical Development & Commercialization
ETHICSDavid Perlman, MDPenn Center for Bioethics
Executive Sponsors:
Supporting Sponsor: Presented by:
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
Dear Colleague,
The Conference Forum has broken through the ceiling in research to present a new standard of content in peer-to-peer learning. Executing Global Clinical Trial Operations is scrupulously researched and approved by industry peers and leaders to ensure a conference event that meets the following learning objectives:
1. Best practices in executing global trials collaboratively with the sponsors, CROs and investigators.
2. How to investigate and identify the right clinical partner to implement your global trial by different regions.
3. Lessons learned from leaders with recent hands-on experience in executing global trials.
4. Peer-to-peer information sharing on the hottest issues cultural differences, resource utilization, data mining and strategies to managing a global trial during an acquisition.
5. Analyze a complex and interactive case study involving several ethical problems in conducting global clinical trials.
6. Best practices on how to win in the contest of speed to complete recruitment vs value in data from representative populations in pivotal clinical trials.
7. Understand the pros and cons of social media and networking for global patient recruitment and the investment risks.
8. Identify the expectations of implementing a global recruitment strategy from beginning to end.
9. Informed consent simplification and improvement strategies.
10. Identify solutions to enhance patient privacy.
11. Best practices on how to conduct global protocols in regions with untested or developing clinical research infrastructures (eg, emerging markets).
12. How to clarify regulatory acceptance of global results for national registrations.
13. Understand epidemiological resources in non-US/EU countries to allow for clinical assessments of disease opportunities, validation of study sites/protocols, conduct of observational/pharmacoepidemiological studies in those countries.
14. Get clarification on what is acceptable with regards to safety reporting, risk evaluation and mitigation plans.
15. Tips on how to create a working environment that is flexible enough to deal with the regulatory environment.
16. Understand what sponsors can do to make the review process easier.
Please take a look at the sessions and speaking faculty. We are confident that this is the most comprehensive and cutting-edge event on executing efficient and safe global clinical trials with patient and partner success.
Sincerely,
Mitchell Katz, PhDExecutive Director, Medical Research OperationsPurdue & Conference Co-Chair
Aleksandar Skuban, MDDirector, Global Development & CommercializationOtsuka Pharmaceutical Development & Commercialization& Conference Co-Chair
The Conference Forum is grateful for the guidance and support of the Global Clinical Trial’s Dedicated Advisory Board:
Larry Blankstein, PhDSenior Director Clinical ResearchGenzyme
Peter Carberry, MDSenior Vice President, Global Development OperationsAstellas
Graeme Currie, PhDVice President, Clinical OperationsSepracor
Shobha Dhadda, PhDAssociate Director, BiostatisticsAstellas
Pierre Etienne, MDInstitut Douglas/Douglas Institute
Chris Gallen, MD, PhDExecutive Vice President of Research and DevelopmentCombinatoRx
Peter K Honig MD, MPHIndependent Consultant
Mitchell Katz, PhDExecutive Director, Medical Research OperationsPurdue
Mark LanfearVIce President, Worldwide Strategic AlliancesKforce
Jack LawlerDirector of Clinical OperationsCephalon
Dilip Mehta, MD, PhDPartnerRadius Ventures, LLC
Gary Meininger, MDDirector, Clinical ResearchMerck
Raymond Panas, PhD Director of International Clinical DevelopmentSucampo Pharmaceuticals
Honorio Silva, MDPresidentInter-American Foundation for Clinical Research
Aleksandar Skuban, MDDirector, Global Development & CommercializationOtsuka Pharmaceutical Development & Commercialization
Linda Strause, PhDExecutive Director, Oncology TrialsVical
Nancy WidnerExecutive Director of Central Clinical OperationsBMS
EXECUTING GLOBAL CLINICAL TRIAL OPERATIONS! ADVISORY BOARD
2
ADVISORY BOARD
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
The Conference Forum is pleased to announce the following
industry leaders who are speaking at this event:
Peter Carberry, MD
Senior Vice President, Global Development Operations
Astellas
Claudia Chavarro
Associate Director, Clinical Operations
RPS
Scott H. Connor
Vice President, Marketing
Acurian, Inc.
Shobha Dhadda, PhD
Associate Director, Biostatistics
Astellas
Mitchell Katz, PhD
Executive Director, Medical Research Operations
Purdue
Ni Khin, MD (invited)
Medical Team Leader
Division of Psychiatry Products
US Food and Drug Administration
Jack Lawler
Director of Clinical Operations
Cephalon
Raymond Panas, PhD
Director of International Clinical Development
Sucampo Pharmaceuticals
Mark Paxton
Assoc. Vice President, International Regulatory & Scientific Affairs
PhRMA
David Perlman, PhD
Senior Lecturer, Penn Nursing
Associate Fellow
Penn Center for Bioethics
Viq Pervaaz
Senior Vice President, Corporate Transaction
AON Consulting
Laurence G. Poli, PhD
Vice President and General Manager
TTC, llc
Brian P. Schrock
Director, Global Enrollment Optimization
Eli Lilly & Company
Honorio Silva, MD
President
Inter-American Foundation for Clinical Research
Aleksandar Skuban, MD
Director, Global Development & Commercialization
Otsuka Pharmaceutical Development & Commercialization
Anne Trontell, MD, MPH
Program Director
AHRQ
Gene Wright, PharmD, PhD
Senior Vice President, Chief Development Officer
CombinatoRx
This event is designed for pharmaceutical and biotech executives
in senior management or director roles with responsibilities in:
• Global Clinical Operations
• Clinical Research & Development
• Clinical Outsourcing
• Clinical Project Management
• Clinical Design
• Clinical Strategy
• Biostatistics
• Patient Recruitment/Enrollment
• Medical Director
• Investigators *
• Ethics
• Protocol Design
• Distribution
• Regulatory Affairs
This conference is also of interest to CROs, Patient Recruitment,
Logistic and Translation companies.
* Please see special rate for Investigators when registering.
• To provide attendees with content that has been scrupulously
researched and approved by industry peers and leaders
• To provide attendees with an experienced speaking faculty
• To provide attendees with stimulating and interactive sessions
• To provide attendees with useful data and information to help
them do their jobs better
SPEAKING FACULTY! EXECUTING GLOBAL CLINICAL TRIAL OPERATIONS
3
WHO SHOULD ATTEND
SPEAKING FACULTY
PRINCIPLES OF THE EVENT
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
8:00! Registration & Morning Coffee/Tea
8:30" Chair’s Welcome and Opening Remarks on How Companies are Coming to the Decision to Execute Global Clinical Trials
Mitchell Katz, PhD
Executive Director, Medical Research OperationsPurdue
8:40! State of the Industry Address • The contrast between trials in the US vs globally
• How to create a working environment that is flexible
enough to deal with the regulatory environment?
• Overview of global requirements for NDA/BLA
applications in established and emerging markets
• Regulatory acceptance of global results for national
registrations (eg, US FDA or CHMP Acceptance of
foreign clinical trial data)
• Conducting global protocols in regions with untested or
developing clinical research infrastructures (eg,
emerging markets)
• Epidemiological resources in non-US/EU countries to
allow for clinical assessments of disease opportunities,
validation of study sites/protocols, conduct of observational/
pharmacoepidemiological studies in those countries
• What PhRMA is doing to support global trials
Mitchell Katz, PhD! Mark Paxton
Executive Director,! Assoc. Vice President,
Medical Research! International Regulatory &
Operations! Scientific Affairs
Purdue! PhRMA
9:30! Grounding Realities in Conducting International Trials -Trans-Regional Regulatory Issues • The CTA approval process in the European Union,
China, India and Latin America
• Timelines predictions
• Country requirements
• Multiple translations
• How to select regional and country regulatory experts
Gene Wright, PharmD, PhD
Senior Vice President, Chief Development Officer
CombinatoRx
10: 15 Updates & Q&ANi Khin, MD (invited)
Medical Team Leader
Division of Psychiatry Products
US Food and Drug Administration
10:45 ! Networking Break
11:15 ! A Breakdown and Comparison of Costs in Conducting Trials Globally (Survey Results)
Laurence G. Poli, PhD
Vice President and General Manager
TTC, llc
11:45 ! Ethical Considerations in Conducting Global TrialsAt the end of this session, participants should be able to:
• Describe and use ethical principles and theories that
underlie clinical research
• Analyze a complex, interactive case study involving
ethical problems in conducting global clinical trials
• Understand several ethical considerations for
particularly "sticky" issues in conducting global clinical
trials, including:
1. medical exploitation
2. use of placebos
3. ensuring proper standards of trial conduct
4. avoiding undue influence in recruitment and
participation
5. ensuring adequate ethical oversight
David Perlman, PhD
Senior Lecturer, Penn Nursing
Associate Fellow
Penn Center for Bioethics
12:30! Luncheon with Round Tables organized by the following RegionsAttendees will have the opportunity to enjoy lunch
followed by the rotation of two regions of their choice
where they can ask questions specific to those regions.
An experienced facilitator will lead each region.
1. Latin America
2. Eastern Europe
3. China
4. Korea
5. Europe
6. India
7. Japan
2:30! 3-Part Patient Recruitment!
Part I - How to Win in the Contest of Speed to Complete Recruitment vs Value in Data from Representative Populations in Pivotal Clinical Trials• Do we simply meet regulatory needs to collect data on
populations of special interest or do we seek to
understand the differing responses to an investigational
medication through stratifying for this phenomenon?
EXECUTING GLOBAL CLINICAL TRIAL OPERATIONS! AGENDA
4
DAY ONE - TUESDAY, SEPTEMBER 28, 2010
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
• Is this a relevant question for every therapeutic area and
indication being studied?
• Do these questions influence and direct country and site
selection? If not, what assumptions, models or
algorithms do we use to address the differences that
show up in the data?
• What is the optimal approach to managing the conflict
between time and need to understand differences, at the
study, program and CTD levels?
• Case studies and examples
Peter Carberry, MD! Shobha Dhadda, PhD
SVP, Global Development! Associate Director,
Operations! Biostatistics
Astellas! Astellas
3:15 ! Part II - Social Media & NetworkingLeveraging eRecruitment for Clinical Trial Enrollment: Case StudyWith Web 2.0 and social media continuing to gain
mindshare with consumers and marketers alike, the focus
surrounding its effectiveness in recruiting patients for
clinical trials has increased dramatically in recent months.
Acurian and Eli Lilly provide insight into the pitfalls and
possibilities of eRecruitment as a global patient enrollment
strategy, including performance metrics from recent trials.
Brian P Schrock! Scott H Connor
Director, Global! Vice President, Marketing
Enrollment Optimization! Acurian, Inc
Eli Lilly & Company
3:45 ! Networking Break
4:00! Part III - Globalization of the Recruitment Strategy and How it Best Applies in Different Regions - Sponsor & CRO Communications in a Global World• Expectations in implementing an end-to-end strategy
• Development and review cycles at the vendor, sponsor,
legal and ethics / regulatory boards
• Addressing the challenges of roles and responsibilities
• Who is accountable to select the sites?" Is it the vendor
or the sponsor?" If the sponsor suggests sites, does the
CRO feel obliged or enabled?"
• The use of EHR data to drive decision-making in trial set
up, both at the CRO and sponsor level
• Cultural differences
• Relationship and communication strategies
• Training
• CRO and site selection
• Enrollment strategies
• Registries for prospective and retrospective studies
• After the recruitment phase is completed, what is the
impact on the country?
• How to follow up with investigators and regulators?
• What are the business implications?
• What about presentation or publication of study results?
• What is the current situation with bridging studies and
intellectual property issues?
• What is the current situation with bridging studies and
intellectual property issues?
• What is being done and what can be done to design
protocols that are more patient focused
• Building the protocol to match the SOC (as much as
possible) and putting strategies in place to make it
simple for both the site and the patients regardless of TA
• Messaging options to patients, and how they are
different in different parts of the world
Open Session
5:00! Networking Reception hosted by
9:00" Chair’s Welcome & Opening RemarksAleksandar Skuban, MD
Director, Global Development &
Commercialization
Otsuka Pharmaceutical Development & Commercialization
9:30" It’s a Team Effort! Best Practices in Executing Trials Globally with the Sponsors, CROs and Investigators With the patient at the center of the trial, Sponsors, CROs
and Investigators present together on each key topic to
identify better solutions to execute clinical trials globally.
This interactive team approach will allow us to better:
1. Understand the key issues and elements around each
topic
2. Provide recommendations and better solutions
More specifically:
• Contracting decisions
• How can you execute to meet the demands for the
timelines?
• Identifying better solutions to get the quality of data you
need and resourcing your clinical trials
• Do any outsourcing models work better than any other?
• What are the key elements that make them work?
• Incentives for performance
• Clinical trial start up and protocol sign up to start up
• First patient treated
• Data base lock and Data privacy
• Patient reported outcomes
AGENDA! EXECUTING GLOBAL CLINICAL TRIAL OPERATIONS
5
DAY TWO - WEDNESDAY, SEPTEMBER 29, 2010
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
EXECUTING GLOBAL CLINICAL TRIAL OPERATIONS! AGENDA
• Global trial distribution
• Identifying better solutions to get drugs, equipment and
patient samples in and out of these emerging countries
• Logistical issues/samples/distribution
Mitchell Katz, PhD! Jack Lawler
Executive Director,! Director of Clinical Operations
Medical Research! Cephalon
Operations
Purdue
Raymond Panas, PhD! Honorio Silva, MD
Director of International! President
Clinical Development! Inter-American Foundation
Sucampo! for Clinical Research
Pharmaceuticals
10:30! Networking Break
11:00! 2-Part Training Investigators!
! Part I - Training Experienced AND Naive Site Investigators: Moving from a One Country Pilot Plan to a Full Implementation Approach across Latin America
Claudia Chavarro
Associate Director, Clinical Operations
RPS
! Part II - Training and Certification of Investigators: Contributions to Leverage Health Care in the Emerging Markets• Investigator in the emerging world (demographics,
distribution, etc. UNESCO data)
• Barriers to efficient clinical research in the USA & abroad
• AAMC recommendations for investigators training and
other regulatory requirements
• On-going programs for training and certification of
investigators (ACRP, Argentina, Brazil, USA," IAFCR) and
expected benefits
Honorio Silva, MD
President
Inter-American Foundation for Clinical Research
11:45 ! How to Investigate and Identify the Right Clinical Partner to Implement your Global Trial• How do you start your search?
• How to seek and network for key opinion leaders?
• Identifying specialties from each region
• Coordinating project teams to work with global CROs
Jack Lawler! Raymond Panas, PhD
Director of Clinical! Director of International
Operations! Clinical Development
Cephalon! Sucampo Pharmaceuticals
12:15 ! Luncheon
1:15 ! Emerging Markets Future Outlook: Economic Definitions, Regulatory and Research Experience From Patient Recruitment to Innovation Hubs • Diverse regions and unique countries
• Changing global landscape: Emerging countries of past,
present and future
• What are the major incentives and advantages of clinical
trials in emerging countries?
• True challenges, ethical questions and possible solutions
• Awareness of health landscape and differences in
medical practices in various countries
• Matching clinical trial indications with patient
populations in need-mutual benefit
• Outsourcing and partnership, getting it right
• Contrasts and similarities among Eastern European
countries in global clinical research
Aleksandar Skuban, MD
Director, Global Development & Commercialization
Otsuka Pharmaceutical Development &
Commercialization
2:00! Open Group Discussion Led by Experienced Facilitators on Peer-to-Peer Information Sharing on Hot TopicsHot topic # 1
Managing Global Clinical Studies During an Acquisition—
Strategies for Maintaining the Focus and Momentum
• When the original team does not go with the acquisition
• How acquisition should work and how they sometimes
work
• Factors to ensure continuity
Hot topic # 2
Cultural impact on study execution
Hot topic # 3
Factors to consider in optimizing resource utilization
Hot topic # 4
The use of data mining techniques to identify patient
locations
Viq PervaazSenior Vice President, Corporate Transaction
AON Consulting
3:00! Comparative Effectiveness• Definition and Methods
• Recent mandate to AHRQ
• HTA in other countries (NICE)
• Objectives and impact of CE on drug development and
payer decision making
Anne Trontell, MD, MPH
Program Director
AHRQ
4:00! Conference concludes
6
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
! Industry! Government, Non-Profit ! ! & InvestigatorsEarly-Bird -Before August 13, 2010! $1495! $595
Standard -After August 13, 2010! $1695! $795
On-siteSep 28-29, 2010! $1795! $895
Fee includes program, morning coffee/tea, lunch, reception and
conference documentation.
Discount InformationIndividual Online Registration - Receive a 5% discount off when
you register online.
Colleague Registration - Receive a 10% discount off each
registration when two colleagues from the same company register.
Group Registration - Receive a 15% discount off each registration
when three or more colleagues from the same company register.
Please contact Customer Service at [email protected]
for large group discounts.
Four Easy Ways to RegisterOnline (Best value!) - www.theconferenceforum.com
Telephone - 646-350-2580
Fax - 917-463-1047
Mail - The Conference Forum, 845 Third Avenue, 6th floor,
New York, NY, 10022
Payment PolicyPayment must be received in full by the event date. All discounts
will be applied to the Conference fee only (excluding add-ons), and
cannot be combined with any other offer.
Substitution and Cancellation PolicyIf you are unable to attend and would like to register a substitute,
please email us at [email protected]. If you need to
cancel your registration, please note the following policies based
on the start date of the event:
Ten or more business days prior: A full refund less the
administration fee of $295, or a pass to another event valid for
two years from the date of issue.
Less than ten business days prior: A pass to a future event for
either yourself or a colleague from the same company valid for two
years from the date of issue.
The Conference Forum guarantees the quality of its conferences.
If you are not satisfied with the quality of the conference, a credit
will be applied towards a comparable program.
Embassy Suites Washington DC - Convention Center900 10th Street NW, Washington DC 20037
Tel: 202-739-2001
The Conference Forum has secured a
block of rooms at a corporate discount
rate. To book your room, please contact
the hotel directly identifying yourself as a
conference attendee to receive the group
rate. Please book early to take advantage,
as rooms may sell out.
Do You Want To Reach the Audience at This Event?#Share your expertise and showcase your product or services to
key industry decision-makers. For information on sponsorship or
exhibit opportunities, please contact our Sales Department at
[email protected] or 646-350-2586. To get involved
as a Press or Media partner, please contact Customer Service at
[email protected] or call 646-350-2585.
The Global Leaders in Clinical Trials is a
professional, social network for the clinical
trials industry, bringing together people
and organizations to find their global
peers, share knowledge and exchange
insights. Membership to this group is free.
For more information, please visit www.theconferenceforum.org.
The Conference Forum is proud to
collaborate with the Inter-American
Foundation for Clinical Research (IAFCR).
The mission of the IAFCR is to foster ethical clinical research as a
means to improve the health of thousands of individuals in the
Americas and thus help lower the gross disparity in health found
within and without the region. For more information, please visit
their website at www.iaclinres.org.
The Conference Forum is proud to support
Lend-A-Hand India in achieving its goal to help
disadvantaged people gain better access to education
and vocational training, particularly in healthcare. For
more information, please visit their website at
www.lend-a-hand-india.org.
REGISTRATION, VENUE & SPONSORSHIP! EXECUTING GLOBAL CLINICAL TRIAL OPERATIONS
7
REGISTRATION VENUE
SPONSORSHIP OPPORTUNITIES
PHILANTHROPIC SUPPORT
PROFESSIONAL NETWORKING
ETHICAL STANDARDS
THE CONFERENCE FORUM GUARANTEE
TO REGISTER, VISIT WWW.THECONFERENCEFORUM.ORG OR CALL 646-350-2580
Acurian is the leading provider of centralized patient recruitment and retention services for the global biopharmaceutical and medical device industries. Company differentiators
include: the world’s largest direct-to-patient database, predictive analytics and enrollment modeling, recruitment and retention management software platforms, and performance-based contracts that offer sponsors unprecedented risk sharing.
RPS, a next generation CRO, provides comprehensive global Phase 1-4 clinical development solutions to the pharma, biotech and medical device industries.
By combining an experienced clinical research operations infrastructure with the industry?s largest resourcing engines, RPS is uniquely positioned to offer our Clients both integrated and full service global outsourcing solutions. These solutions are powered by highly experienced and seasoned study teams providing innovative, cost-effective and high quality services.
BBK Worldwide is the global leader in patient recruitment for the clinical R&D segments of the pharm and biotech industries. Since 1983, BBK has accelerated time-to-market for new medicines and treatments by
successfully supporting thousands of studies in more than 60 countries and in all major phases and therapeutic areas.
TTC, headquartered in Philadelphia and founded by Dr. Harold Glass, offers the largest current database of investigator budgets from 60 countries. TTC carries five
distinctive products that deliver state of the art cost benchmarking tools. With nearly 100 clients who conduct over 75% of the clinical trials around the world, TTC is ready to serve all companies with specific programs tailored to meet their customized requirements.
PharmaVOICE magazine, reaching more than 20,500 BPA-qualified life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges
and trends impacting the industry. PharmaVOICE, and its supporting VIEW publications, provide readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Additionally, PharmaVOICEMarketplace.com provides a directory of products, services, and solutions for the life sciences industry. To Raise Your VOICE, contact [email protected].
With a BPA-qualified circulation of 18,250 clinical trial professionals worldwide, Applied Clinical Trials has earned the status as the
industry’s most trusted source for professionals who design, initiate, manage, conduct and monitor clinical trials.
CenterWatch is the global source for clinical trials information for professionals and
patients. Visit www.centerwatch.com to learn about our many services, including our new complimentary grant notification service, TrialWatch for Sites http://www.centerwatch.com/news-resources/trialwatch/signup/.
Medical News Today is the largest independent medical and health news site on the web - with over 2,000,000 unique monthly users it is
ranked #1 for medical news on Google and Yahoo!. Medical News Today is used by Blue Chip pharmaceutical/health organizations, advertising agencies, PR companies and vertical ad networks to deliver targeted disease/condition and general health campaigns. For more information contact [email protected] or visit www.medicalnewstoday.com.
pharmaphorum is a universal site for the industry online where everyone can share constructive ideas and opinions, or just ask
others for advice. It is a hub for constructive industry debate and sharing of ideas. www.pharmaphorum.com
Innovaro Pharmalicensing is the leading global resource for partnering, licensing, and business development in the life science and
biopharmaceutical industries. Their services complement and enhance business development activity throughout the deal-making process – from finding the perfect partner to closing the deal. Visit them at www.pharmalicensing.com
Pharmaceutical Outsourcing is a journal dedicated to pharmaceutical and biopharmaceutical contract services. With
regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry.
Report Buyer is the intelligent way to buy pharma & healthcare market research online. Browse and choose from a current and comprehensive range of specialised
intelligence from leading publishers. Trusted by information professionals across the world, Report Buyer's mission is to help you find the right business intelligence.
The Leading Provider of Intelligence to the Biotechnology & Pharmaceutical Industry
• Detailed company profiles for over 4,100 biotech & pharmaceutical companies
• Listings on 36,000+ investigational & 23,000+ approved drugs
• Contact info for 250,000+ industry contacts (includes email & direct phone)
SPONSORS AND MEDIA PARTNERS! EXECUTING GLOBAL CLINICAL TRIAL OPERATIONS
EXECUTIVE SPONSORS
8
MEDIA PARTNERS
SUPPORTING SPONSOR
EXHIBITOR